TY - JOUR
T1 - Efficient amyloid A clearance in the absence of immunoglobulins and complement factors
AU - Sponarova, Jana
AU - Nuvolone, Mario
AU - Whicher, Charlotte
AU - Frei, Nathalie
AU - Kana, Veronika
AU - Schwarz, Petra
AU - Westermark, Gunilla T.
AU - Aguzzi, Adriano
N1 - Funding Information:
Supported by the Swiss National Research Foundation , the Novartis Research Foundation , the Clinical Research Focus Program of the University of Zurich , and the European Union FP7 programs LUPAS and PRIORITY . A.A. is the recipient of a European Research Council Advanced Investigator Award; J.S. is supported by a Federation of the European Biochemical Societies long-term fellowship ; M.N. was supported in part by an investigator fellowship from Collegio Ghislieri, Pavia, Italy; G.T.W. is supported by the Swedish Research Council ( 2010-55x-20326-04-3 ).
PY - 2013/4
Y1 - 2013/4
N2 - Amyloid A amyloidosis is a protein misfolding disease characterized by deposition of extracellular aggregates derived from the acute-phase reactant serum amyloid A protein. If untreated, amyloid A amyloidosis leads to irreversible damage of various organs, including the kidneys, liver, and heart. Amyloid A deposits regress upon reduction of serum amyloid A concentration, indicating that the amyloid can be efficiently cleared by natural mechanisms. Clearance was proposed to be mediated by humoral immune responses to amyloid. Here, we report that amyloid clearance in mice lacking complement factors 3 and 4 (C3C4-/-) was equally efficient as in wild-type mice (C57BL/6), and was only slightly delayed in agammaglobulinemic mice (JH-/-). Hence, antibodies or complement factors are not necessary for natural amyloid clearance, implying the existence of alternative physiological pathways for amyloid removal.
AB - Amyloid A amyloidosis is a protein misfolding disease characterized by deposition of extracellular aggregates derived from the acute-phase reactant serum amyloid A protein. If untreated, amyloid A amyloidosis leads to irreversible damage of various organs, including the kidneys, liver, and heart. Amyloid A deposits regress upon reduction of serum amyloid A concentration, indicating that the amyloid can be efficiently cleared by natural mechanisms. Clearance was proposed to be mediated by humoral immune responses to amyloid. Here, we report that amyloid clearance in mice lacking complement factors 3 and 4 (C3C4-/-) was equally efficient as in wild-type mice (C57BL/6), and was only slightly delayed in agammaglobulinemic mice (JH-/-). Hence, antibodies or complement factors are not necessary for natural amyloid clearance, implying the existence of alternative physiological pathways for amyloid removal.
UR - https://www.scopus.com/pages/publications/84875153424
U2 - 10.1016/j.ajpath.2012.12.035
DO - 10.1016/j.ajpath.2012.12.035
M3 - Article
C2 - 23454183
AN - SCOPUS:84875153424
SN - 0002-9440
VL - 182
SP - 1297
EP - 1307
JO - American Journal of Pathology
JF - American Journal of Pathology
IS - 4
ER -